678 related articles for article (PubMed ID: 26415590)
1. Fibroblast growth factor-21, energy balance and obesity.
Giralt M; Gavaldà-Navarro A; Villarroya F
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
[TBL] [Abstract][Full Text] [Related]
2. Modulation of energy balance by fibroblast growth factor 21.
Cuevas-Ramos D; Aguilar-Salinas CA
Horm Mol Biol Clin Investig; 2016 Jun; 30(1):. PubMed ID: 27318658
[TBL] [Abstract][Full Text] [Related]
3. Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice.
Maekawa R; Seino Y; Ogata H; Murase M; Iida A; Hosokawa K; Joo E; Harada N; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Hayashi Y; Arima H
J Nutr Biochem; 2017 Nov; 49():71-79. PubMed ID: 28886439
[TBL] [Abstract][Full Text] [Related]
4. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
5. FGF21 mimetic antibody stimulates UCP1-independent brown fat thermogenesis via FGFR1/βKlotho complex in non-adipocytes.
Chen MZ; Chang JC; Zavala-Solorio J; Kates L; Thai M; Ogasawara A; Bai X; Flanagan S; Nunez V; Phamluong K; Ziai J; Newman R; Warming S; Kolumam G; Sonoda J
Mol Metab; 2017 Nov; 6(11):1454-1467. PubMed ID: 29107292
[TBL] [Abstract][Full Text] [Related]
6. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.
Laeger T; Baumeier C; Wilhelmi I; Würfel J; Kamitz A; Schürmann A
Diabetologia; 2017 Nov; 60(11):2274-2284. PubMed ID: 28770320
[TBL] [Abstract][Full Text] [Related]
7. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.
Díaz-Delfín J; Hondares E; Iglesias R; Giralt M; Caelles C; Villarroya F
Endocrinology; 2012 Sep; 153(9):4238-45. PubMed ID: 22778214
[TBL] [Abstract][Full Text] [Related]
8. Brown Adipose YY1 Deficiency Activates Expression of Secreted Proteins Linked to Energy Expenditure and Prevents Diet-Induced Obesity.
Verdeguer F; Soustek MS; Hatting M; Blättler SM; McDonald D; Barrow JJ; Puigserver P
Mol Cell Biol; 2015 Oct; 36(1):184-96. PubMed ID: 26503783
[TBL] [Abstract][Full Text] [Related]
9. Levels of β-klotho determine the thermogenic responsiveness of adipose tissues: involvement of the autocrine action of FGF21.
Moure R; Cairó M; Morón-Ros S; Quesada-López T; Campderrós L; Cereijo R; Hernáez A; Villarroya F; Giralt M
Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E822-E834. PubMed ID: 33615874
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic Effects of FGF21 Are Independent of the "Browning" of White Adipose Tissue.
Véniant MM; Sivits G; Helmering J; Komorowski R; Lee J; Fan W; Moyer C; Lloyd DJ
Cell Metab; 2015 May; 21(5):731-8. PubMed ID: 25955208
[TBL] [Abstract][Full Text] [Related]
11. FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue.
Markan KR; Naber MC; Small SM; Peltekian L; Kessler RL; Potthoff MJ
Mol Metab; 2017 Jun; 6(6):602-610. PubMed ID: 28580290
[TBL] [Abstract][Full Text] [Related]
12. FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity.
Ye M; Lu W; Wang X; Wang C; Abbruzzese JL; Liang G; Li X; Luo Y
Endocrinology; 2016 Dec; 157(12):4754-4769. PubMed ID: 27690692
[TBL] [Abstract][Full Text] [Related]
13. FGF21-Mediated Improvements in Glucose Clearance Require Uncoupling Protein 1.
Kwon MM; O'Dwyer SM; Baker RK; Covey SD; Kieffer TJ
Cell Rep; 2015 Nov; 13(8):1521-7. PubMed ID: 26586424
[TBL] [Abstract][Full Text] [Related]
14. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue.
Hondares E; Gallego-Escuredo JM; Flachs P; Frontini A; Cereijo R; Goday A; Perugini J; Kopecky P; Giralt M; Cinti S; Kopecky J; Villarroya F
Metabolism; 2014 Mar; 63(3):312-7. PubMed ID: 24369918
[TBL] [Abstract][Full Text] [Related]
16. FGF21 Mediates the Thermogenic and Insulin-Sensitizing Effects of Dietary Methionine Restriction but Not Its Effects on Hepatic Lipid Metabolism.
Wanders D; Forney LA; Stone KP; Burk DH; Pierse A; Gettys TW
Diabetes; 2017 Apr; 66(4):858-867. PubMed ID: 28096260
[TBL] [Abstract][Full Text] [Related]
17. FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms.
BonDurant LD; Ameka M; Naber MC; Markan KR; Idiga SO; Acevedo MR; Walsh SA; Ornitz DM; Potthoff MJ
Cell Metab; 2017 Apr; 25(4):935-944.e4. PubMed ID: 28380381
[TBL] [Abstract][Full Text] [Related]
18. FGF21: A Novel Regulator of Glucose and Lipid Metabolism and Whole-Body Energy Balance.
Szczepańska E; Gietka-Czernel M
Horm Metab Res; 2022 Apr; 54(4):203-211. PubMed ID: 35413740
[TBL] [Abstract][Full Text] [Related]
19. Potential roles of fibroblast growth factor 21 in the brain.
Sa-Nguanmoo P; Chattipakorn N; Chattipakorn SC
Metab Brain Dis; 2016 Apr; 31(2):239-48. PubMed ID: 26738728
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast Growth Factor 21 and the Adaptive Response to Nutritional Challenges.
Martínez-Garza Ú; Torres-Oteros D; Yarritu-Gallego A; Marrero PF; Haro D; Relat J
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]